The pharmaceutical industry is facing increasing challenges due to growing pressure from politicians regarding drug prices, resulting in calls for changes in patent policies. This tension has raised doubts about the future of pharmaceutical innovation, particularly as the industry navigates government restructuring on drug pricing. While long-term innovation may remain robust, short-term uncertainties loom as investments in pharmaceutical research become increasingly risky. The industry must confront these issues directly to ensure that it can lower drug prices while maintaining a commitment to innovation.
The two big problems facing the pharmaceutical industry are price controls and an exaggerated incentive to abandon small molecule drugs in favor of biologics.
The pharmaceutical industry has been squeezed both with price controls and bad patent policy, which calls into question the future of pharmaceutical innovation.
Collection
[
|
...
]